Skip to main content
SpringerLink
Log in

T lymphocyte killing by a xanthine-oxidase-containing immunotoxin

  • Short communication
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

We report on the preparation of an immunotoxin consisting of xanthine oxidase, a free-radicalproducing enzyme, covalently linked to an anti-CD3 monoclonal antibody. The immunotoxin retained both enzymic and immunological properties and its toxicity to target cells (a) was greater than that of the free enzyme, (b) was proportional to the enzyme concentration, and (c) was reduced either in the absence of hypoxanthine or by an excess of free anti-CD3 monoclonal antibody. The cytotoxicity and selectivity of the hypoxanthine/conjugated xanthine oxidase system were potentiated by the addition of chelated iron and by washing away the unbound immunotoxin prior to the addition of substrate. The same system was not toxic to bone marrow progenitor cells. A possible use of this immunotoxin for the ex vivo purging of organs to be transplanted from T lymphocytes, to avoid the graft-versus-host reaction, is suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Battelli MG (1980) Enzymic conversion of rat liver xanthine oxidase from dehydrogenase (D-form) to oxidase (O-form). FEBS Lett 113: 47

    PubMed  Google Scholar 

  2. Battelli MG, Abbondanza A, Tazzari PL, Dinota A, Rizzi S, Grassi G, Gobbi M, Stirpe F (1988) Selective cytotoxicity of an oxygen-radical-generating enzyme conjugated to a monoclonal antibody. Clin Exp Immunol 73: 128

    PubMed  Google Scholar 

  3. Battelli MG, Abbondanza A, Dinota A, Tazzari PL, Stirpe F (1991) Xanthine oxidase-containing immunotoxins. J Chemother 3 [Suppl 3]: 241

    Google Scholar 

  4. Blakey DC, Wawrzynczak EJ, Wallace PM, Thorpe PE (1988) Antibody toxin conjugates: a perspective. Prog Allergy 45: 50

    PubMed  Google Scholar 

  5. Chiricolo M, Tazzari PL, Abbondanza A, Dinota A, Battelli MG (1991) Cytotoxicity of, and DNA damage by, active oxigen species produced by xanthine oxidase. FEBS Lett 291: 173

    PubMed  Google Scholar 

  6. Della Corte E, Stirpe F (1968) The regulation of rat-liver xanthine oxidase: activation by proteolytic enzymes. FEBS Lett 2: 83

    PubMed  Google Scholar 

  7. Della Corte E, Stirpe F (1972) The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type 0) and purification of the enzyme. Biochem J 126: 739

    PubMed  Google Scholar 

  8. Dinota A, Tazzari PL, Abbondanza A, Battelli MG, Gobbi M, Stirpe F (1990) Bone marrow purging by a xanthine oxidase-antibody conjugate. Bone Marrow Transplant 6: 31

    PubMed  Google Scholar 

  9. Fraker PJ, Speck JC Jr (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3 a,6 a-diphenylglycoluril. Biochem Biophys Res Commun 80: 849

    PubMed  Google Scholar 

  10. Frankel AE (1988) Immunotoxins, Kluwer, Boston

    Google Scholar 

  11. Halliwell B (1978) Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelators. FEBS Lett 92: 321

    PubMed  Google Scholar 

  12. Ito H-O, Morizet J, Coulombel L, Goavec M, Rousseau V, Bernard A, Stanislawski M (1989) An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097. Bone Marrow Transplant 4: 519

    PubMed  Google Scholar 

  13. Kuppusamy P, Zweier JL (1989) Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation. J Biol Chem 264: 9880

    PubMed  Google Scholar 

  14. Lemoli RM, Gasparetto C, Scheinberg DA, Moore MAS, Clarkson BD, Gulati SC (1991) Autologous bone marrow transplantation in acute myelogenous leukemia: In vitro treatment with myeloid specific monoclonal antibodies and drugs in combination. Blood 77: 1829

    PubMed  Google Scholar 

  15. Link EM, Riley PA (1988) Role of hydrogen peroxide in the cytotoxicity of the xanthine/xanthine oxidase system. J Biol Chem 249: 391

    Google Scholar 

  16. McMichael AJ (1987) Leucocyte typing III. Oxford University Press, Oxford, UK

    Google Scholar 

  17. Muzykantov VR, Trubetskaya OV, Puchnina EA, Sakharov DV, Domogatsky SP (1990) Cytotoxicity of glucose oxidase conjugated with antibodies to target cells: killing efficiency depends on the conjugate internalization. Biochim Biophys Acta 1053: 27

    PubMed  Google Scholar 

  18. Senter PD (1990) Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy. FASEB J 4: 188

    PubMed  Google Scholar 

  19. Stanislawski M, Rousseau V, Goavec M, Ito H-O (1989) Immunotoxins containing glucose oxidase and lactoperoxidase with tumoricidal properties: in vitro effectiveness in a mouse plasmocytoma cell model. Cancer Res 49: 5497

    PubMed  Google Scholar 

  20. Stirpe F, Della Corte E (1969) The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type 0). J Biol Chem 244: 3855

    PubMed  Google Scholar 

  21. Stirpe F, Higgins T, Tazzari PL, Rozengurt E (1991) Stimulation by xanthine oxidase of 3T3 Swiss fibroblasts and human lymphocytes. Exp Cell Res 192: 635

    PubMed  Google Scholar 

  22. Tazzari PL, Gobbi M, Dinota A, Bontadini A, Grassi G, Cerato C, Cavo M, Pileri S, Caligaris-Cappo F, Tura S (1987) Normal and neoplastic plasma cell membrane phenotype: studies with monoclonal antibodies. Clin Exp Immunol 70: 192

    PubMed  Google Scholar 

  23. Tazzari PL, Battelli MG, Abbondanza A, Dinota A, Rizzi S, Gobbi M, Stirpe F (1989) Targeting of a plasma cell line with a conjugate containing xanthine oxidase and the monoclonal antibody 62B1. Transplantation 48: 119

    PubMed  Google Scholar 

  24. Tazzari PL, Bolognesi A, Gobbi M, Tassi C, Rizzi S, Vitale M, Pileri S, Conte R, Wijdenes J, Herve P, Soria M, Stirpe F (1992) B-B10 (anti-CD25)-saporin immunotoxin: a possible tool in GVHD treatment. Transplantation (in press)

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Pathology, University of Bologna, Italy

    M. G. Battelli, A. Abbondanza, P. L. Tazzari, A. Bolognesi & F. Stirpe

  2. Institute of Haematology, University of Bologna, Italy

    R. M. Lemoli

Authors
  1. M. G. Battelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Abbondanza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. L. Tazzari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Bolognesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. M. Lemoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Stirpe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Battelli, M.G., Abbondanza, A., Tazzari, P.L. et al. T lymphocyte killing by a xanthine-oxidase-containing immunotoxin. Cancer Immunol Immunother 35, 421–425 (1992). https://doi.org/10.1007/BF01789022

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01789022

Key words

Search

Navigation